World / Science & Health Aug 28, 2014
Glaxo's Ebola vaccine may begin safety tests in humans next week
U.S. scientists will begin enrolling patients as soon as next week in clinical safety trials of GlaxoSmithKline PLC's experimental Ebola vaccine as the death toll from the disease rises in West Africa. The National Institutes of Health's Vaccine Research Center received approval from the Food ...
